CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced that Mark H.N. Corrigan, MD, President and CEO is scheduled to present at the Biotech Showcase 2011 Conference at 10:30 a.m. PT on January 11, 2011, at the Parc 55 Wyndham San Francisco. Interested parties may access a live webcast of the presentation by visiting the Zalicus website at www.zalicus.com or through the provider’s website http://www.ccbn.com/conferences/26851/BiotechShowcase/2011/2011-01-10/signup.html. The webcast will be archived on the Zalicus website following the event.
